Organovo (ONVO) News Today → You won't believe what Citigroup just did to it's depositors (From American Alternative) (Ad) Free ONVO Stock Alerts $0.97 -0.03 (-3.00%) (As of 05/29/2024 ET) Add Compare Share Share HeadlinesStock AnalysisChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainSEC FilingsShort InterestTrendsStock AnalysisChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainSEC FilingsShort InterestTrends All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative May 28 at 1:30 AM | americanbankingnews.comOrganovo (NASDAQ:ONVO) Earns Sell Rating from Analysts at StockNews.comMay 21, 2024 | globenewswire.comOrganovo Data Presented at Digestive Disease Week (DDW2024) Demonstrating Potential for FXR314 as Combination Therapy with Tofacitinib for Inflammatory Bowel DiseaseMay 20, 2024 | americanbankingnews.comStockNews.com Initiates Coverage on Organovo (NASDAQ:ONVO)May 14, 2024 | globenewswire.comOrganovo to Present Data on FXR314 at Digestive Diseases Week (DDW2024)May 8, 2024 | globenewswire.comOrganovo Holdings, Inc. Announces Pricing of $5.25 Million Public OfferingMay 1, 2024 | finance.yahoo.comONVO Announces Very Positive Phase 2 ResultsApril 15, 2024 | msn.comWhy Organovo Stock Is Up TodayApril 15, 2024 | reuters.comOrganovo's fatty liver disease drug meets main goal in mid-stage studyApril 15, 2024 | globenewswire.comOrganovo Announces Positive Phase 2 Results for FXR314 in Metabolic Dysfunction-Associated Steatohepatitis (MASH) Showing Both Reduction in Liver Fat Content and Strong Safety and Tolerability Compared to PlaceboFebruary 24, 2024 | benzinga.comOrganovo Holdings Stock (NASDAQ:ONVO) Earnings Dates and Earning CallsFebruary 10, 2024 | finance.yahoo.comOrganovo Holdings Third Quarter 2024 Earnings: EPS Beats Expectations, Revenues LagFebruary 9, 2024 | morningstar.comOrganovo Holdings Inc ONVOFebruary 9, 2024 | finance.yahoo.comONVO Continues ProgressFebruary 8, 2024 | sfgate.comOrganovo: Fiscal Q3 Earnings SnapshotFebruary 8, 2024 | msn.comOrganovo Holdings Unveils Corporate Presentation OnlineJanuary 25, 2024 | finance.yahoo.comOrganovo Presents FXR314 3D Human Tissue Model Findings That Show Improved Epithelial Barrier Function and Fibrosis Reduction at Crohn’s and Colitis CongressJanuary 9, 2024 | finance.yahoo.comOrganovo To Present FXR314 IBD 3D Model Findings at Upcoming Crohn’s and Colitis CongressDecember 7, 2023 | finanznachrichten.deOrganovo, Inc.: Organovo Provides Timing for Release of FXR314 Phase 2 NASH ResultsDecember 6, 2023 | finance.yahoo.comOrganovo Provides Timing for Release of FXR314 Phase 2 NASH ResultsNovember 13, 2023 | msn.comOVNO Continues Developing Breakthrough TreatmentsNovember 13, 2023 | finance.yahoo.comCORRECTION – Organovo Highlights FXR314 Combination Therapy Potential and PlanNovember 11, 2023 | finance.yahoo.comOrganovo Holdings Second Quarter 2024 Earnings: US$0.46 loss per share (vs US$0.38 loss in 2Q 2023)November 8, 2023 | finance.yahoo.comOrganovo Highlights FXR314 Combination Therapy Potential and PlanNovember 7, 2023 | msn.comONVO, FATH and BYU among mid-day moversOctober 10, 2023 | finance.yahoo.comONVO: A Company With Great Technology to Impact Health CareSeptember 8, 2023 | finance.yahoo.comOrganovo to Participate in the H.C. Wainwright Global Investment ConferenceAugust 25, 2023 | finance.yahoo.comIs Organovo Holdings (ONVO) Too Good to Be True? A Comprehensive Analysis of a Potential Value TrapAugust 23, 2023 | finance.yahoo.comOrganovo Advances Clinical Timelines for FXR314 and Provides Updates on NASH Phase 2 DataAugust 16, 2023 | msn.comOnvo receives $3 million grant from PennDOT to enhance electric vehicle charging infrastructureJuly 29, 2023 | seekingalpha.comONVO Organovo Holdings, Inc.July 20, 2023 | msn.comOnvo introduces first public fast electric vehicle chargers on I-81 stretchJune 7, 2023 | fool.comOrganovo (NASDAQ: ONVO)March 21, 2023 | finance.yahoo.comOrganovo Announces FXR ProgramFebruary 10, 2023 | finance.yahoo.comWill Organovo Holdings (NASDAQ:ONVO) Spend Its Cash Wisely?October 25, 2022 | finance.yahoo.comOrganovo Holdings, Inc. (ONVO)October 17, 2022 | finance.yahoo.comTrends in 3D-Printing Materials Technology and the Global Market for the Most Promising New 3D-Printing Materials Applications - Yahoo FinanceOctober 12, 2022 | benzinga.comHuman Liver Models Market Size Share Trends Growth Demand and Competitive Analysis Insights 2022-2029 | D - BenzingaOctober 9, 2022 | globenewswire.com3D Bioprinting Market Size to Touch Valuation of $1.5 Billion by 2028 | Inkjet Technology Generates More than 38% Revenue of Bioprinting Market - GlobeNewswireOctober 3, 2022 | seekingalpha.comARKG: Too Hard To Pin Down, Too Volatile For Comfort (BATS:ARKG) - Seeking AlphaSeptember 30, 2022 | prnewswire.comGlobal Laboratory Animal Models, 3D Cultures and Organoids Markets, 2019-2021 & 2022-2027 - Opportunities in Organoids in Drug Development, Personalized Medicine and Transplantational Medicine - PR NewswireSeptember 30, 2022 | businesswire.comGlobal Human Liver Model Market Report 2022: Emerging 3D and 2D Trends in Modeling Human Liver Disease in Vitro Fuel Growth - ResearchAndMarkets.com - Business WireSeptember 29, 2022 | businesswire.com3D Bioprinting Global Market Report 2022: Long-term Forecasts to 2026 & 2031 Featuring Organovo Holdings, Allevi, Cellink, Aspect Biosystems, & 3D Systems - ResearchAndMarkets.com - Business WireSeptember 23, 2022 | benzinga.comWhy Spero Therapeutics Is Trading Higher By Over 105%; Here Are 21 Stocks Moving Premarket - American Vir - BenzingaSeptember 22, 2022 | uk.investing.comWhy Spero Therapeutics Is Trading Higher By Over 105%; Here Are 21 Stocks Moving Premarket By Benzinga - Investing.com UKSeptember 16, 2022 | nasdaq.comPre-market Movers: DWIN, SES, KSPN, NRBO, EPM… - NasdaqSeptember 16, 2022 | uk.investing.comWhy Applied Optoelectronics Is Trading Higher By Around 31%; Here Are 21 Stocks Moving Premarket By Benzinga - Investing.com UKSeptember 14, 2022 | rttnews.comPre-market Movers: DWIN, SES, KSPN, NRBO, EPM… - RTTNewsSeptember 6, 2022 | globenewswire.comOrganovo to Participate in the H.C. Wainwright 24th Annual - GlobeNewswireSeptember 6, 2022 | globenewswire.comOrganovo Announces Postponement of Annual Meeting of Stockholders - GlobeNewswireSeptember 6, 2022 | finance.yahoo.comOrganovo Announces Postponement of Annual Meeting of Stockholders Get Organovo News Delivered to You Automatically Sign up to receive the latest news and ratings for ONVO and its competitors with MarketBeat's FREE daily newsletter. Email Address Who are Nvidia’s New Silent Partners? (Ad)Nvidia recently became just the third $2 trillion company. But Nvidia can’t do everything by itself. I call these Nvidia’s “Silent Partners.” ONVO Media Mentions By Week ONVO Media SentimentLearn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. ONVO News Sentiment▼1.190.79▲Average Medical News Sentiment ONVO News CoverageLearn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. ONVO Articles This Week▼40▲ONVO Articles Average Week Get Organovo News Delivered to You Automatically Sign up to receive the latest news and ratings for ONVO and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies: Genetic Technologies News Today BioCardia News Today Inhibikase Therapeutics News Today Coeptis Therapeutics News Today Sorrento Therapeutics News Today Scinai Immunotherapeutics News Today Tevogen Bio News Today Microbot Medical News Today Creative Medical Technology News Today Titan Pharmaceuticals News Today Headlines Tools: Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:ONVO) was last updated on 5/29/2024 by MarketBeat.com Staff From Our PartnersShocking $16T Elon Musk Crypto LeakCrypto 101 MediaBiden replacement revealed?Paradigm PressThis Apple-like Innovator is Revolutionizing HealthcareWall Street Star4 Cryptos BETTER than BitcoinTrue Market InsidersMissed NVDA? Buy this AI stock NOWChaikin AnalyticsDo This Before July 30 2024 To Claim Trump’s Gift Wealthpin ProShocking: One AI startup's revenue could surge 4,735%Manward PressWrite this ticker symbol down…StocksToTrade Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Organovo Holdings, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
